Rosacea

We’re all in this for good.

By sharing your stories and data, you will:
  • help each other live better and uncover the best ways to manage your health today
  • help researchers shorten the path to new treatments tomorrow

How much good can your data do? A whole lot, as co-founder Jamie Heywood explains in this video.

What is Rosacea?

Rosacea is a chronic skin condition involving inflammation of the cheeks, nose, chin, forehead, or eyelids. It may appear as redness, prominent spider-like blood vessels, swelling, or skin eruptions similar to acne.

What is it like to have Rosacea?

Common symptoms How bad it is What people are taking for it
Alprazolam, Lorazepam, Clonazepam
Hydrocodone-Acetaminophen, Ibuprofen, Tramadol
Zolpidem, Amitriptyline, Quetiapine
Rest, Modafinil, Naps
Duloxetine, Sertraline, Bupropion

What do patients take to treat Rosacea and its symptoms?

Treatments reported by members Perceived effectiveness Overall rating of side effects # of Evaluations

(Flagyl)

3

(Klaron, Rosaderm Cleanser, Ovace Plus)

1

(Acne-Clear, Brevoxyl Acne Wash Kit, Clean and Clear Advantage Acne Control Cleanser, Proactive Solution Cleanser Extra Strength Formula)

0
0

These charts show data from Rosacea patients’ latest treatment evaluations
Last updated:

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell
  • Severe
  • Moderate
  • Mild
  • None

Who has Rosacea on PatientsLikeMe?

  • 279 patients have this condition
  • 2 new patients joined this month
  • 74 say Rosacea is their primary condition

Age
Age Proportion # of patients
<20 1
20s 13
30s 57
40s 90
50s 68
60s 28
70+ 2

Gender

Distribution of females vs. males

85% Females
15% Males
Age at first symptom
Age at first symptom Proportion # of patients
0-19 years 22
20-29 years 32
30-39 years 42
40-49 years 29
50-59 years 11
60-69 years 2
70+ years 0

Diagnosis status
Diagnosis status Proportion # of patients
Diagnosed 176
Not Diagnosed 12

These charts show data from Rosacea patients who have completed their condition history
Last updated: